Louisiana said it was adopting a Netflix-subscription model in order to pay for expensive hepatitis C medications. On Thursday, the state sent solicitation to find a drug manufacturer as partner.
Medicine January 11, 2019
A couple filed a lawsuit against HealthPlus Surgery Center alleging it exposed nearly 3,800 patients to bloodborne infections. One patient has so far tested positive for hepatitis C.
Public Health December 30, 2018
The HealthPlus Surgery Center in Saddle Brook sent out a letter to 3,778 patients who may have been exposed to blood-borne infection. Most of those at risk are from New York and New Jersey.
Public Health December 25, 2018
A man who donated his blood in 2003 apparently had a rare form of hepatitis C. The man was given a new treatment that he credits for saving his life after the shocking diagnosis.
Medicine May 22, 2018
Cora Weber, the nurse suspected of spreading hepatitis C, has admitted to taking discarded drugs from the hospital she worked at but denied having the virus or reusing needles on patients. Her lawyers also highlight she is a regular blood donor.
Public Health May 10, 2018
Cora Weberg is reportedly the only nurse at the Good Samaritan Hospital who treated both of the patients who tested positive for hepatitis C. Her license is now suspended.
Public Health May 8, 2018
One of the patients who had contact with a hepatitis-C infected nurse at MultiCare Good Samaritan Hospital in Puyallup filed a lawsuit over hospital negligence. The suit was filed after the arrest of the nurse, Cora Weberg.
Public Health May 6, 2018
A nurse at the MultiCare Good Samaritan Hospital in Puyallup, Washington, may have infected 2,600 patients with hepatitis C. The nurse no longer works there, and the hospital is offering free tests to potentially infected patients.
Public Health May 2, 2018
The Centers for Disease Control and Prevention reports of higher hepatitis C incidences due to the heroin epidemic. The report calls for state policies for HCV prevention, and testing for at risk individuals.
Public Health May 12, 2017
The new syringe vending machines in Las Vegas, Nevada will dispense clean needles for free to reduce the spread of HIV and hepatitis C. How do these machines work?
Public Health April 15, 2017
A research committee has laid out a plan to successfully eradicate hepatitis B and C from the United States by 2030. The plan suggests that the federal government acquire license rights for expensive drugs used to treat these diseases.
Public Health March 29, 2017
A dentist at the Tomah Veterans Affairs Medical Center possibly exposed 592 veterans to HIV, hepatitis B and hepatitis C by failing to follow standard infection control procedures. The dentist had been using his own equipment, cleaning and reusing it.
Public Health December 3, 2016
The FDA warned against the potential risk of Hepatitis B virus reactivation in patients treated with direct-acting antiviral drugs for Hepatitis C. 'Boxed Warnings' about Hepatitis B reactivation risks on antiviral drug labels are now mandated.
Medicine October 5, 2016
FDA green-lighted the first drug that can treat all major forms of the viral disease hepatitis C. How effective is Gilead's Epclusa and how much does it cost?
Medicine June 29, 2016
Hepatitis C infections are now killing more people in the US than other infections combined, according to a new CDC report. The data pointed to hepatitis C in baby boomers as well as new worrisome virus transmission routes.
Public Health May 5, 2016
An antiviral treatment combination is potentially effective in eradicating Hepatitis C virus (HCV) among patients after six to 12 weeks, a new study has revealed. The treatment may further improve clinical practices.
Life April 19, 2016
Hepatitis C may increase the risk for certain types of head and neck cancers, researchers say. Sadly, more than 3.5 million Americans are infected with this virus and are unaware of the same.
Life April 18, 2016
PeaceHealth St. John Medical Center has notified nearly 300 patients who might have been exposed to HIV, Hepatitis B and Hepatitis C. The likelihood of infection is extremely low, but the hospital is still exercising caution and offering tests to concerned patients.
Life April 7, 2016
Drug loans or health care loans (HCL) are proposed to provide patients with payment terms for expensive Hepatitis C and cancer drugs. HCL was presented to an MIT conference, with insurance companies in attendance.
Life March 30, 2016
Merck is set to receive $200 million in damages from Gilead Sciences as federal jury decides on patent dispute. Merck claims they should be credited for liver therapy breakthrough.
Life March 25, 2016
A federal jury favored Merck & Co. over Gilead Sciences Inc. in a high-profile lawsuit involving patents for new hepatitis C drugs. Merck sued Gilead for using sofosbuvir in hepatitis drugs Sovaldi and Harvoni.
Life March 23, 2016
Millions of Americans are infected by the hepatitis C virus. The FDA approval for Zepatier provides patients with genotype 1 and 4 infections another treatment option to improve prognosis for their condition.
Life January 29, 2016
A U.S. Senate probe showed that Gilead Sciences planned to maximize profits for its hepatitis C drugs, with affordability and patient access as a mere “afterthought.” The investigation centered on the costs of Sovaldi and combination drug Harvoni.
Life December 2, 2015
The Baywatch star poses a racy photo on Instagram to announce that she is finally free of hepatitis C. Anderson was diagnosed with the disease in 2001 and underwent a new FDA-approved drug regimen in early 2015.
Life November 10, 2015
Sixty-seven employees of a pharmaceutical company in New Jersey are facing a health scare. The company discovered that the nurse who administered the flu vaccine did not change the syringes in between shots.
Life October 9, 2015
Obama’s Advisory Council on HIV/AIDS strongly urges the White House to push for a wider access to new Hepatitis C drugs, including Gilead’s thousand-dollar Harvoni and Sovaldi pills.
Life August 26, 2015
For committing a number of violations, a blood bank in Miami was closed down by the FDA. The agency has not done anything like this in more than 10 years.
Life July 18, 2015
Restrictions imposed by many state Medicaid programs are preventing patients with hepatitis C to have access to Sovaldi, an effective but costly treatment for the disease.
Life June 30, 2015
China rejected a patent application of Gilead Sciences for its hepatitis C drug Sovaldi. Advocacy group I-MAK said that the decision could pave way for other countries to reject the company's application as well.
Life June 21, 2015
Hepatitis C is the most common blood-borne infection in the United States and it’s currently making its rounds in West Virginia, Virginia, Tennessee and Kentucky.
Life June 7, 2015
Gilead is facing opposition in five countries for its patent applications for Sovaldi, a hepatitis C drug. Activists launched the patent oppositions to ensure access to treatment for the disease.
Life May 22, 2015
Health administrators in Scott County, Indiana are pushing for the extension of the needle exchange program for a year. The program, which is set to expire on May 24, has produced positive results in curbing the spread of the HIV disease in the county.
Life May 21, 2015
WHO updates Essential Medicines List to include hepatitis C medications, expanding and promoting off-label drug use in the process to improve treatment for a variety of serious conditions.
Life May 8, 2015
Getting hepatitis C is already a major concern by itself, but researchers have found that acquiring the infection also increases risk for various types of cancer.
Life April 29, 2015
Laboratory research shows cheap allergy medicine can be an alternative treatment for hepatitis C patients.
Life April 9, 2015
Zydus and Gilead Sciences bring Hepatitis C drug SoviHep to India. Between 150 million and 200 million people across the world suffer from Hepatitis C.
Life March 18, 2015
According to a drug trend report, hepatitis C medications account for a spike in prescription drug spending not seen in over 10 years despite representing just a percent of purchases.
Life March 10, 2015
Achillion Pharmaceuticals shows rapid progress in the development of a new drug that aims to treat patients with hepatitis C within a six-week treatment period.
Life February 10, 2015
Researchers have found a way to jam the code that governs how viruses replicate and this could stop virus molecules from copying themselves and causing diseases. The findings could pave the way for improved treatments of the common cold, HIV, and Hepatitis C.
Life February 6, 2015
Widespread screening is a good way to detect disease, but is it necessary? In hepatitis C, some scientists believe it is not. They also call into question the treatments being offered.
Life January 15, 2015
CVS and Gilead Sciences strike an exclusive deal for hepatitis drugs Sovaldi and Harvoni. The total cost of treatment via Sovaldi can reach up to $84,000 for 12 weeks.
Life January 9, 2015
Publishers of the journal Science have announced their contest for scientific breakthrough of the year is down to five finalists. Here is how you can vote for your favorite!
December 6, 2014
Hepatitis C will cost thousands a week to treat, but costs will still be lower than what it would take to cover complications arising from the infection later on.
Life October 22, 2014
The Food and Drug Administration approved Gilead's Harvoni drug that aims to cure hepatitis C. It costs $94,500 over a 12-week program, equivalent to $1,125 daily.
Life October 11, 2014
Expensive hepatitis C drug Sovaldi, which has been developed by Gilead Sciences, will be cheaper in developing countries. Seven Indian companies will manufacture the drug.
Life September 16, 2014
Feature | Science
Feature | Health